muscle, adipose tissue, and liver) associated with glucose intolerance and obesity (26, 27) . Insulin resistance in liver results from an increased flux through glucose-6-phosphatase (21) , whereas insulin resistance in peripheral tissues results from a defect in glucose transport (16) and/or glucose phosphorylation followed by a reduction in both the rate of muscle glycogen synthesis and glucose oxidation (22) . Because these physiological alterations mimic those reported in patients with type 2 diabetes (3, 4) , it is of interest to try to better understand their molecular basis. Defects in insulin signaling in peripheral tissues have been reported during a high-fat diet, but the alterations reported are not uniform between muscle and adipose tissue (10) . In muscle, the total amount of insulin receptor was reduced without modification of the receptor affinity (11) ; insulin receptor substrate (IRS)-1 and IRS-2 proteins were not affected, although their phosphorylation was reduced (1); and the activation of phosphatidylinositol (PI) 3Ј-kinase was reduced (1, 36) . In addition, an alteration in intrinsic activity (23) , translocation (36) , or expression (14) of GLUT-4 has been observed. Taken together, these results suggest an impairment in the early steps of insulin signaling that could involve insulin receptor and IRS-1 tyrosine phosphorylation as well as PI 3Ј-kinase activity. In adipose tissue, in contrast to muscle, a high-fat diet reduced the IRS-1 and IRS-2 proteins, whereas both the mRNA and the amount of GLUT-4 were reduced in muscle (1, 7, 13, 24) . In liver, IRS-1 and IRS-2 proteins and their phosphorylation were not altered, and PI 3Ј-kinase activity associated with IRS-1 and IRS-2 was increased, suggesting that the alterations of insulin signaling responsible for the insulin resistance of liver differ from those implicated in the insulin resistance of peripheral tissues (1) .
However, not all types of fatty acids induce an alteration of insulin action during a high-fat diet in rats (27) . Indeed, the substitution of n-3 long-chain polyunsaturated fatty acid (PUFA) from fish oil for other types of lipids prevents insulin resistance (12, 17, 28) . The mechanisms sustaining such a protective effect of n-3 PUFA remain unclear. The effects of dietary n-3 PUFA could be related to the subsequent changes in fatty acid content in membrane phospholipids of insulin target tissues (14) . In muscle, n-3 PUFA might improve insulin sensitivity through a relative increase in unsaturation of membrane phospholipids and/or a decrease in muscle content in triglycerides (21, 25, 35) . The alterations in membrane composition could affect insulin receptors (19) and/or IRS-1 and PI 3Ј-kinase expression and protein abundance (15) . In adipose tissue, conversely to muscle, the defect in glucose transport induced by a high-fat diet is not affected by n-3 PUFA, which may result from reduced insulin receptor number and tyrosine kinase activity (8, 28) . In liver, the impact of n-3 PUFA on insulin resistance is to date unclear. This effect of n-3 PUFA could be the result of a prevention of the increased glucose cycle activity, either associated or not with reduced hepatic fatty acid oxidation, which is known to promote gluconeogenesis (12, 17, 21) . Taken together, these studies suggest that n-3 PUFA may have a tissue-specific impact in restoring insulin sensitivity. However, the early steps of insulin signaling have not been studied in liver and have been studied only partially in peripheral tissues from animals fed a high-fat diet.
In the present study, we examined the effects of a high-fat diet containing n-6 PUFA or one containing n-6 and n-3 PUFA on insulin signaling in liver, muscle, and mRNA expression of some components of insulin signaling in addition to leptin in adipose tissue.
MATERIALS AND METHODS
Animal care and tissue preparation. All animal studies were conducted in accordance with the principles and procedures outlined in the Institut National de la Recherche Agronomique Guide for the Care and Use of Laboratory Animals. Thirty male Wistar rats aged 5 wk were housed in a temperature-, humidity-, and light-controlled room. Rats were placed on a laboratory chow diet (60% carbohydrates-12% lipids-28% protein) and water ad libitum for the first 5 wk. Next, they were divided into three groups (n ϭ 10/group). Rats received either laboratory chow (control rats), a high-fat diet rich in n-6 PUFA (n-6 rats), or a high-fat diet rich in n-3 PUFA (n-3 rats). The laboratory chow contained, as a percentage of calories, 22% casein, 6% peanut oil, 8% canola oil, 58% starch, and 6% sucrose. The high-fat diet rich in n-6 PUFA contained 58% fat from safflower oil, 16% casein, 21% starch, and 5% sucrose. The high fat-diet rich in n-3 PUFA contained 39% fat from safflower oil, 19% fat from fish oil, 16% casein, 21% starch, and 5% sucrose. The content in fatty acids of each diet is reported in Table 1 . The three groups of rats received these diets for 4 wk. Rat body weights and food consumption were measured every week. At the end of the 4-wk period, animals in each of the three groups were subdivided into two groups of five rats. One group received an intraperitoneal injection of saline, and the other group received an intraperitoneal injection of insulin (100 mU/kg). The treatment was performed in the morning. Treated animals were returned to their cages and fed their respective feed. Seven minutes later, animals were killed. After neck dislocation, blood was collected, and plasma was prepared immediately and stored at Ϫ20°C until subsequent analysis. Liver, leg muscles, and adipose tissue were collected, immediately frozen in liquid nitrogen, and stored at Ϫ80°C.
Determination of plasma glucose and insulin concentrations in fed rats. Plasma glucose concentrations were measured by the glucose oxidase method (Glucose Beckman Analyzer 2; Beckman, Palo Alto, CA). Plasma insulin concentrations were determined with an RIA kit (Linco Research, St. Louis, MO) using rat insulin standards.
Extraction and analysis of lipids. Total lipid extracts (from diets and rat tissues) were obtained by the method of Folch et al. (9) . Triglycerides and phospholipids were separated and purified by using TLC on silica gel with hexane-diethyl etheracetic acid (70:30:1) as the developing solvent. Fatty acids were determined by direct methylation with boron trifluoride-methanol (90 min at 100°C), and spots were scraped from TLC plates. Methyl esters of fatty acids obtained were diluted in hexane before separation by gas chromatography.
Determination of insulin receptor density in liver membranes. Liver membranes were prepared as previously described (30) . Aliquots of 50-l crude membranes (0.4 mg/ml) were incubated for 16 h at 4°C with 125 I-labeled insulin at 0.1 ng/ml in the absence or presence of increasing concentrations of unlabeled monocomponent porcine insulin (4-40,000 ng/ ml). The assay was terminated by centrifugation of the tubes at 12,000 g for 3 min at 4°C. The pellets were washed with 0.2 ml chilled sucrose (0.25 M), and radioactivity was counted. Nonspecific binding was determined in the presence of an excess of cold insulin. The competition curves were analyzed using Graph Pad software (version 2.00).
Immunoprecipitations and Western blotting procedures. Powdered tissues (1 g) were homogenized, solubilized, and ultracentrifuged as previously described (6). The superna- tants were either directly submitted to Western blotting or to immunoprecipitation before Western blotting. For direct application, 10-20 g of solubilized muscle proteins were submitted to SDS-PAGE and electrotransferred to nitrocellulose membranes. Next, membranes were incubated with different primary antibodies directed toward insulin receptor or GLUT-4. Blots were then revealed by enhanced chemiluminescence after incubation with horseradish peroxidase conjugated with specific secondary antiserum (Pierce). For the immunprecipitation procedure, 500 g of solubilized liver or muscle proteins were immunoprecipitated with an antiphosphotyrosine antibody (␣-PY20; 1:200) at 4°C over 16 h. The immune complexes were precipitated with protein A-agarose for 1 h at 4°C, as previously described (32) . Immunoprecipitates were resolved by SDS-PAGE and transferred to nitrocellulose membranes, and Western blotting was performed as described above using ␣-PY20 or ␣-IRS-1 (antibodies directed toward IRS-1). PI 3Ј-kinase assay. PI 3Ј-kinase was determined as previously described (18, 31) . Briefly, the liver and muscles were homogenized, solubilized, and ultracentrifuged. The supernatants were immunoprecipitated overnight at 4°C with ␣-PY20 (1:200). PI 3Ј-kinase was measured in immunoprecipitates in the presence of phosphatidylinositol and labeled ATP. The radioactivity incorporated in phosphatidylinositol was quantified with a STORM apparatus (Molecular Dynamics).
Determinations of IR, IRS-1, p85, GLUT-4, and leptin expressions using RT-PCR in rat adipose tissue.
Total RNAs from adipose tissue were extracted using an RNA Insta Pure kit according to the manufacturer's recommendations (Eurogentec). Total RNAs were submitted to RT-PCR as previously described (6) . RT reactions were primed with random hexamer primers, and PCR was carried out in the presence of various pairs of primers. The PCR primers used were as follows: insulin receptor (IR), 5Ј-primer, 5Ј-TTTGGGATGGTTTATGAGGG-3Ј, and 3Ј-primer, 5Ј-GCCAGGTCTCTGTGAACAAA-3Ј(flanking a region of 235 bp); IRS-1, 5Ј-primer, 5Ј-GCCCGGCCCACGAGGC-TG-3Ј, and 3Ј-primer, 5Ј-GCAATGCCTGTTGGCATG-3Ј(flanking a region of 490 bp); p85, 5Ј-primer, 5Ј-AACCTTCAACTCTGT-GGTTG-3Ј, and 3Ј-primer, 5Ј-TGATTCTTTGCTGTACCGCT-3Ј (flanking a region of 336 bp); GLUT-4, 5Ј-primer, 5Ј-GAACAT-GGCGAACCCCCTAC-3Ј, and 3Ј-primer, 5Ј-CTGCTGGCTCA-GTGCAGCAC-3Ј(flanking a region of 800 bp); leptin, 5Ј-primer, 5Ј-ACACGTCGGTATCCGCCAAG-3Ј, and 3Ј-primer, 5Ј-AGCA-GATGGAGGAGGTCTCG-3Ј (flanking a region of 194 bp); 18S RNA, 5Ј-primer, 5Ј-CTGCCCTATCAACTTTCG-3Ј, and 3Ј-primer, 5Ј-GGCGTCGATCCTTATTAC-3Ј (flanking a region of 515 bp).
Statistics. Statistical analyses were performed using ANOVA to detect significant intergroup differences (ANOVA; STATVIEW software). Comparisons between two groups were performed by Student's unpaired t-test analysis. All results are expressed as means Ϯ SE, and P Ͻ 0.05 was considered statistically significant.
RESULTS
Basal parameters. Rats consuming a hyperlipidic diet (n-6 rats or n-3 rats) showed a significant (P Ͻ 0.05) weight gain compared with rats receiving the control diet (control rats), as reported in Fig. 1A and Table 2 . The n-6 and n-3 rats consumed less feed after the second week of the diet (Fig. 1B) , as indicated Table  2 and Fig. 1B (expressed as g/day) . The consumed energy calculated from these values shows that n-6 and n-3 rats consumed 125.8 and 128.5 kcal/day, respectively, whereas control rats consumed 118.7 kcal/day.
Glucose and insulin plasma levels. Significantly higher glycemia and insulinemia were observed in n-6 and n-3 rats compared with control rats (Table 2 ). In n-6 and n-3 rats, insulin plasma levels were increased by 190% (P Ͻ 0.05) and glucose plasma levels by 124% (P Ͻ 0.05) compared with the control group (100%).
Impact of a hyperlipidic diet (n-6 and n-3) on the composition of muscle, liver, and adipose tissue lipids.
The fatty acid content in membrane phospholipids of muscle, liver, and adipose tissue is shown in Fig. 2 . As expected, the total amount of lipids in muscle, liver, and adipose tissue is significantly higher in n-3 and n-6 rats compared with control rats. However, the degree of enrichment is dependent on tissues. The positive impact of n-3 PUFA is mostly dependent on the ratio n-3 to n-6 or n-3 to total fatty acids. For this, we have also expressed the results as a ratio of PUFA (n-3) to total saturated fatty acid ( Fig. 2A) , PUFA (n-3) to PUFA (n-6) (Fig. 2B ), and 20:5 (n-3) to 20:4 (n-6) (Fig.  2C ) in all studies. Figure 2 shows that the most affected or enriched tissue in n-3 PUFA was muscle compared with liver and adipose tissue. In addition, the ratio of PUFA (n-3) to PUFA (n-6), PUFA (n-3) to total saturated fatty acid, or 20:5 (n-3) to 20:4 (n-6) was similar in adipose tissue of control and n-6 rats.
Effect of hyperlipidic (n-6 and n-3) diets on liver and muscle insulin receptor density. In liver, hyperlipidic n-6 and n-3 diets significantly (P Ͻ 0.05) reduced IR number by 28.6 and 46.4%, respectively, compared with rats fed a standard diet (Fig. 3A) . IR affinity toward the hormone was not affected with an EC 50 (concentration of cold insulin that inhibits 50% of 125 I-insulin binding) of 27.8 Ϯ 3.4, 29.6 Ϯ 6.4, and 27.5 Ϯ 4 ng/ml in control, n-6, and n-3 rats, respectively (Fig. 3A, inset) . In muscle, because of the high nonspecific binding of iodinated insulin to muscle crude membranes, IR content was estimated by Western blotting using specific anti-IR antibodies, as described in MATERIALS AND METHODS. Figure 3B shows that muscle IR content was not significantly affected by the hyperlipidic diets, as estimated by the Western blot technique.
Impact of hyperlipidic diet (n-6 and n-3) on IR and IRS-1 tyrosine phosphorylation and PI 3Ј-kinase activity in liver. Intraperitoneal insulin injection increased liver IR tyrosine phosphorylation in control rats (Ϫin-sulin ϭ 58; ϩinsulin ϭ 87, as arbitrary units measured using NIH Image Software), whereas in n-6 (Ϫinsu-lin ϭ 82; ϩinsulin ϭ 66 arbitrary units) and n-3 (Ϫin-sulin ϭ 62; ϩinsulin ϭ 64 arbitrary units) rats, the insulin effect was completely abolished (Fig. 4A) .
Insulin stimulated IRS-1 tyrosine phosphorylation in control rats (Ϫinsulin ϭ 100; ϩinsulin ϭ 138) but not in n-6 (Ϫinsulin ϭ 123; ϩinsulin ϭ 107 arbitrary Data are means Ϯ SE; n ϭ 10 rats. * P Ͻ 0.05. Fig. 2 . Fatty acid composition of muscle, liver, and adipose tissue membrane phospholipids. Wistar rats (30 wk old) were divided into 3 groups and fed with the control (C rats), n-6 PUFA (n-6 rats), or n-3 PUFA (n-3 rats) diet. After 4 wk of diet, phospholipid fatty acid composition was measured in liver, muscle, and adipose tissue. Results were expressed as PUFA (n-3)-total saturated fatty acid (TSFA) (A), PUFA (n-3)-PUFA (n-6) (B), and 20:5 (n-3)-20:4 (n-6) (C).
Fig. 3. Insulin receptor (IR) density in liver (
A) and muscle (B) of C, n-6, and n-3 rats. Wistar rats (5 wk old) were subjected to the control, n-6 PUFA, or n-3 PUFA diet for 4 wk, and then liver and muscles were removed. A: crude liver membranes were used to perform insulin-binding studies to measure insulin receptor density and insulin receptor affinity (EC50). Results are expressed as means Ϯ SE. *P Ͻ 0.05. units) or n-3 (Ϫinsulin ϭ 101; ϩinsulin ϭ 83 arbitrary units) rats (Fig. 4B) . Insulin stimulated PI 3Ј-kinase activity in control rats, whereas in both n-6 (P Ͻ 0.05) and n-3 (P Ͻ 0.05) rats the insulin effect was completely abolished (Fig. 4C) .
Impact of hyperlipidic diet (n-6 and n-3) on IR, IRS-1, and PI 3Ј-kinase activity in muscle.
Insulin induced the tyrosine phosphorylation of IR in control rats (Ϫinsulin ϭ 120; ϩinsulin ϭ 140 arbitrary units) and n-3 rats (Ϫinsulin ϭ 58; ϩinsulin ϭ 108 arbitrary units) but not in n-6 rats (Ϫinsulin ϭ 125; ϩinsulin ϭ 124 arbitrary units). In addition, the basal tyrosine phosphorylation of the IR ␤-subunit was higher in n-6 rats than in control and n-3 rats (Fig. 5A) .
In control rats, insulin induced the phosphorylation of IRS-1 (Ϫ insulin ϭ 140; ϩinsulin ϭ 217 arbitrary units). In n-3 rats, insulin slightly induced the phosphorylation of IRS-1 (Ϫinsulin ϭ 105; ϩinsulin ϭ 120 arbitrary units), whereas, in n-6 rats, the insulin effect was not observed and IRS-1 phopshorylation was even reduced (Ϫinsulin ϭ 194; ϩinsulin ϭ 129 arbitrary units; Fig. 5B ).
Insulin clearly stimulated PI 3Ј-kinase activity in control and n-3 rats but not in n-6 rats (Fig. 5C ).
In addition, GLUT-4 protein content was reduced in n-6 rat muscles (191 arbitrary units) relative to control rats (214 arbitrary units), as band densities were quantified using NIH Image software. In n-3 rats, the muscle GLUT-4 content was similar to the level of control rats (207 arbitrary units; Fig. 5D ). Fig. 5 . Insulin receptor and IRS-1 tyrosine phosphorylation, GLUT-4 content, and PI 3Ј-kinase activity in muscle. Male Wistar rats (5 wk old) subjected to the control, n-6 PUFA, or n-3 PUFA diet for 4 wk received an ip dose of placebo (saline, Ϫ) or 100 mU insulin/kg (ϩ) and were killed after 7 min in the fed state. A: muscle lysates were immunoprecipitated with ␣-PY20 and blotted with ␣-PY20 to identify the ␤-subunit of insulin receptor. B: muscle lysates were immunoprecipitated with ␣-PY20 and blotted with ␣-IRS-1 to identify IRS-1. C: muscle lysates were immunoprecipitated with ␣-PY20, and PI 3Ј-kinase activity was measured in the immunoprecipitate. Results are expressed as a ratio of insulin stimulated over placebo treatment and as means Ϯ SE. *P Ͻ 0.05; n ϭ 5 rats. D: muscle lysates from placebo-treated animals were subjected to Western blot and revealed with ␣-GLUT-4. Data are representative of two different animals from each treatment. Fig. 4 . Insulin receptor and insulin receptor substrate (IRS)-1 tyrosine phosphorylation and phosphatidylinositol (PI) 3Ј-kinase activity in liver. Male Wistar rats subjected to the control, n-6 PUFA, or n-3 PUFA diet for 4 wk received an ip dose of placebo (saline, Ϫ) or 100 mU insulin/kg (ϩ) and were killed after 7 min in the fed state. A: liver lysates were immunoprecipitated with ␣-PY20 and blotted with ␣-PY20 to identify the ␤-subunit of insulin receptor. B: liver lysates were immunoprecipitated with ␣-PY20 and blotted with ␣-IRS-1 to identify IRS-1. C: liver lysates were immunoprecipitated with ␣-PY20, and PI 3Ј-kinase activity was measured in the immunoprecipitate. Results are expressed as ratio of insulin stimulated over placebo treatment and as means Ϯ SE. *P Ͻ 0.05; n ϭ 5 rats.
Adipose tissue IR, IRS-1, PI 3Ј-kinase regulatory subunit (p85), GLUT-4, and leptin mRNA expressions.
To study the impact of the high-fat diets (n-6 or n-6 and n-3) on insulin receptor signaling components (IR, IRS-1, p85, and GLUT-4) and on leptin, the corresponding mRNAs were quantified using RT-PCR and were expressed as the ratio over the expression of 18S RNA, as described in MATERIALS AND METHODS. Figure 6 shows that IR and IRS-1 mRNA expression was not altered by the high-fat diets. The expression of the regulatory subunit of PI 3Ј-kinase (p85) was significantly (P Ͻ 0.05) reduced in n-6 and n-3 rats compared with control rats. GLUT-4 and leptin expressions were significantly diminished in n-6 rats, whereas their expression was similar in n-3 rats compared with control rats (Fig. 6) .
DISCUSSION
The present study shows that a high-PUFA diet (n-6 or n-3) increases body weight and energy consumption and is associated with elevated glycemia and insulinemia. Furthermore, an n-6 or n-6 and n-3 high-PUFA diet also affects target tissue lipid composition (liver, muscle, and adipose tissue), and muscle appears to be most enriched in the n-3 PUFA diet. This indicates that muscle, liver, and adipose tissue were differently affected by the fatty acid composition of a diet. The results from this study also demonstrate that a high-PUFA diet in rats affects the early steps of insulin signaling, depending on both the fatty acid composition of the diet and the tissue in which insulin exerts its effects. We clearly showed that both n-6 and n-6 and n-3 high-fat diets induced a striking reduction in insulin receptor density in liver and a blunting of the effect of insulin on IR and IRS-1 tyrosine phosphorylation and PI 3Ј-kinase activity. This indicates a profound alteration of the early steps of insulin receptor signaling in liver. To our knowledge, this is the first study reporting such impact of an n-6 or n-6 and n-3 high-PUFA diet on liver. Our results contrast with those reported in the liver of rats fed a high-saturated-fat diet (1), where IRS-1 tyrosine phosphorylation was maintained and PI 3Ј-kinase activity was increased. Taken together, our results and those from Anai et al. (1) indicate that the type of fatty acids (saturated vs. PUFA) in a high-fat diet has a major specific impact on insulin signaling in liver. They also suggest that the impact of dietary fatty acid on hepatic glucose production may involve PI 3Ј-kinase activity and that the liver insulin resistance induced by a high-fat diet in rats is prevented when fatty acids (saturated, monounsaturated, or n-6 PUFA) are partially substituted with n-3 PUFA (27) . We can speculate that glucose-6-phosphatase and/or glucokinase activities could be the target of n-3 PUFA inasmuch as an increase in glucose cycle activity was observed in liver of rats with liver insulin resistance induced by a high-fat diet (21) .
In muscle, converse to what was observed in the liver, the n-6 diet had different effects from those of a mixed n-6 and n-3 diet, and this may corroborate the fact that muscle and liver are differently affected by the fatty acid composition of diets. The n-6 PUFA led to the blunting of IR and IRS-1 tyrosine phosphorylation in response to insulin injection despite a mild change in IR density. In addition, the stimulating effect of insulin on PI 3Ј-kinase activity was also blunted, and GLUT-4 protein was depressed. In rats fed the n-6 and n-3 diet, insulin signaling was not altered despite the partial reduction in IRS-1 phosphorylation. Thus, in contrast to liver, the partial substitution of n-3 PUFA for n-6 PUFA almost completely maintains the insulin sensitivity of the IR signaling cascade compared with control rats. Importantly, the total amount of GLUT-4 was also maintained at the level of control rats. These results may at least partially explain the recovery of glucose uptake after substitution of n-6 PUFA with n-3 PUFA in a high-fat diet (28) . Indeed, the rate of glucose uptake depends on the amount of GLUT-4 in membrane cells in response to insulin. Because GLUT-4 translocation (not determined in our study) is related to PI 3Ј-kinase activity (5), it is likely that muscle glucose uptake by n-3 PUFA rats was related to the normal insulin signaling cascade activation. Despite normal sensitivity of insulin signaling in muscle, n-3 rats display subnormal glycemia and insulinemia like n-6 rats, which strongly suggests an insulin resistance. This is most likely attributed to the similar degree of obesity associated with insulin resistance and/or the preexistence of a liver insulin resistance limiting the beneficial effect of n-3 PUFA. However, such explanations remain hypothetical, since our study did not aim to determine hepatic glucose production and tissue glucose utilization.
In n-3 and n-6 rats, the adiposity was higher compared with control rats, which reduced protein extraction yield in the adipose tissue. Therefore, we have investigated the expression of insulin signaling components at the level of RNA messengers. We show that n-6 and n-6 and n-3 diets did not alter IR and IRS-1 expressions, but both diets reduced the expression of the regulatory subunit (p85) of PI 3Ј-kinase. This dif- Fig. 6 . Insulin receptor, IRS-1, PI 3Ј-kinase regulatory (p85) subunit, GLUT-4, and leptin mRNA expression in adipose tissue. Total RNA was prepared from adipose tissue of 5-wk-old male Wistar rats subjected to the control, n-6 PUFA, or n-3 PUFA diet for 4 wk. Total RNA was used to perform RT-PCR, which was primed with specific primers for IR, IRS-1, p85, GLUT-4, or leptin. The intensity of mRNA expression was measured using NIH Image software, and results are expressed as means Ϯ SE. *P Ͻ 0.05; n ϭ 5.
fers from what has been reported during a high saturated fat diet where both IRS-1 and p85 expressions were reduced (1). Interestingly, GLUT-4 and leptin expressions were reduced after the n-6 diet and not after the n-6 and n-3 diet compared with control rats. These observations demonstrate that, in adipose tissue, the effect of n-3 PUFA on p85 expression dissociated from their effect on GLUT-4. Because the increased adiposity associated with insulin resistance may affect leptin expression, we have also studied the impact of an n-3 diet compared with an n-6 diet, and we showed that the expression of leptin was altered in n-6 rats but not in n-3 rats. The alteration of leptin expression in n-6 rats was not related to energy balance, weight gain, or energy intake because these parameters are similar to those of n-3 rats. Therefore, the effect of a high-fat diet on leptin expression in adipose tissue is primarily determined by the type of fatty acids ingested and not by weight gain. It is important to note that the difference in leptin expression did not affect energy intake during the three experimental diets. Whether the parallel effect of n-3 PUFA on leptin and GLUT-4 expression results from a common mechanism was not assessed in our study.
The basic mechanisms sustaining the tissue specificity of the effect of an n-6 and n-6 and n-3 diet remain unclear. During the n-6 and n-3 diet, n-3 PUFA incorporated in membrane phospholipids of liver, muscle, and adipose tissue. The incorporation of n-3 fatty acids in phospholipids relative to the control diet was not strikingly different between tissues during the n-6 and n-3 diet. However, the incorporation of n-3 PUFA in triglycerides was quite higher in liver than in muscle or adipose tissue. Whether the incorporation of n-3 PUFA in membrane phospholipids or in triglycerides is a prerequisite for their effect on insulin signaling remains to be determined. Data in rats and humans showing a relationship between glucose uptake in muscle and unsaturation of membranes phospholipids (25, 29) suggest that, whatever the basic mechanism, alteration of the fatty acid content of membranes could play a role.
The antagonist effect of n-3 PUFA against the alteration of the early steps of insulin signaling and as the expression of the regulatory subunit of PI 3Ј-kinase (p85) in adipose tissue is of special interest, especially regarding potential implications for patients with type 2 diabetes. In such patients, a defect in the PI 3Ј-kinase pathway in muscle (2) and a defect in the expession of p85 in muscle and adipose tissue in response to insulin have been demonstrated (33) . Whether n-3 PUFA could restore the insulin sensitivity of PI 3Ј-kinase activity and expression in diabetic subjects merits further investigation. The antagonizing effect of n-3 PUFA against the reduction of leptin expression in adipose tissue could also have major implications for insulin resistance in humans. Unger et al. (33) recently proposed that one of the roles of leptin was to confine triglyceride storage in adipocytes, preventing excessive depots in other tissues. An excess storage of triglycerides in muscle and in ␤-cells participates in insulin resistance (29) , defective insulin secretion via the Randle cycle, and lipotoxicity (34) , which reinforces the two main alterations responsible for type 2 diabetes. The restoration of leptin expression could also be important in restoring muscle glucose utilization inasmuch as leptin administration in rats stimulates glucose uptake in muscle independent of any alteration of GLUT-4 expression or protein abundance (34) .
In summary, this is to our knowledge the first study to establish a clear effect of a high-fat diet enriched in n-3 fatty acids on insulin signaling. A high-fat diet enriched in n-3 fatty acids maintained IR, IRS-1 tyrosine phosphorylation, PI 3Ј-kinase activity, and total GLUT-4 content in muscle but not in liver. At the level of gene expression, a high-fat diet enriched in n-3 fatty acids partially maintained the expression of p85 and totally that of GLUT-4 and leptin mRNA in adipose tissue. Despite these positive effects, rats fed with n-3 PUFA still showed hyperglycemia and hyperinsulinemia, indicating that liver insulin sensitivity impairment strongly contributes to insulin resistance.
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